ConductScience.org, home

Paper17417627

p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.

Song H and 2 others. Nat Cell Biol, 2007. Cited by 373 papers, by iCite.

Cite this record

ConductScience Library. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Papers, record 17417627. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17417627

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
PubMed
Journal
Nat Cell Biol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
373
iCite
Relative citation ratio, by iCite
6.66
iCite
Revised in PubMed
2026-01-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Song HHoseok
2Hollstein MMonica
3Xu YYang

Source PubMed

Download CSV of authors

Topics32

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Cycle ProteinsMajor topic
Cell Transformation, NeoplasticMajor topic
DNA-Binding ProteinsMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Genomic InstabilityMajor topic
MutationMajor topic
Protein Serine-Threonine KinasesMajor topic
Signal TransductionMajor topic
Tumor Suppressor Protein p53Major topic
Tumor Suppressor ProteinsMajor topic
ATP-Binding Cassette Transporters
Acid Anhydride Hydrolases
Animals
Ataxia Telangiectasia Mutated Proteins
Cell Cycle
Cells, Cultured
DNA Breaks, Double-Stranded
DNA Repair Enzymes
Fibroblasts
Histones
Humans
MRE11 Homologue Protein
Mice
Mice, Transgenic
Neoplasms
Nuclear Proteins
Phosphorylation
Proto-Oncogene Proteins c-mdm2
Thymus Gland
Transcription, Genetic
Translocation, Genetic
Ultraviolet Rays

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA77563NCI NIH HHSUnited StatesR01CA077563PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in17473858p53: a two-faced cancer gene.https://conductscience.org/library/papers/17473858

Source PubMed

Download CSV of comments and corrections

Cited by260

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 373 citations.

PMIDTitleJournalYearIn PapersSource
42881229Restoration of p53 function via hybrid strontium sulfite nanoparticles modified LNP improves the antitumor efficacy in breast cancers.Cancer Gene Ther2026https://conductscience.org/library/papers/42881229PubMed
42533115p53 hotspot mutants attenuate CTL-mediated tumor cell killing through a novel ALKBH5-YTHDF3-PD-L1 pathway.Oncogene2026https://conductscience.org/library/papers/42533115PubMed
42352266The Enigmatic Tumor Suppressor p53 Biomolecule: Its Role and Prognostic and Predictive Values in Cancer Therapy and Precision Medicine.Biomolecules2026https://conductscience.org/library/papers/42352266PubMed
41928956Mutant p53 Directs PARP to Regulate Replication Stress and Drive Breast Cancer Metastasis.bioRxiv2026https://conductscience.org/library/papers/41928956PubMed
41588183Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage.Cell Death Differ2026https://conductscience.org/library/papers/41588183PubMed
41535270A scalable two-step genome editing strategy for generating full-length gene-humanized mice at diverse genomic loci.Nat Commun2026https://conductscience.org/library/papers/41535270PubMed
41473985Multiple ETS family transcription factors bind mutant p53 via distinct interaction regions.FEBS Lett2026https://conductscience.org/library/papers/41473985PubMed
41468163Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment.J Clin Invest2026https://conductscience.org/library/papers/41468163PubMed
40729726A clinical guide to TP53 mutations in myeloid neoplasms.Blood2025https://conductscience.org/library/papers/40729726PubMed
40699691In Silico Design of Quantitative Polymerase Chain Reaction (qPCR) Assay Probes for Prostate Cancer Diagnosis, Prognosis, and Personalised Treatment.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699691PubMed
40287981Mutant p53 Gain of Function: Why Many See It, Why Some Do Not.Cancer Discov2025https://conductscience.org/library/papers/40287981PubMed
40210861Mutant p53 upregulates HDAC6 to resist ER stress and facilitates Ku70 deacetylation, which prevents its degradation and mitigates DNA damage in colon cancer cells.Cell Death Discov2025https://conductscience.org/library/papers/40210861PubMed
40001547The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations.Biomolecules2025https://conductscience.org/library/papers/40001547PubMed
39944631Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53.Front Pharmacol2025https://conductscience.org/library/papers/39944631PubMed
39845333Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function mutation.Genes Cancer2025https://conductscience.org/library/papers/39845333PubMed
39836208[Next generation sequencing (NGS)-based molecular panel analysis for metastatic prostate cancer: how often can we detect druggable mutations? : NGS for metastatic adenocarcinoma of the prostate].Urologie2025https://conductscience.org/library/papers/39836208PubMed
39644062Are TP53 mutations all alike?Hematology Am Soc Hematol Educ Program2024https://conductscience.org/library/papers/39644062PubMed
39538363From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.Biomark Res2024https://conductscience.org/library/papers/39538363PubMed
39439908Emerging roles of cancer-associated histone mutations in genomic instabilities.Front Cell Dev Biol2024https://conductscience.org/library/papers/39439908PubMed
39421986PARP Pioneers: Using BRCA1/2 Mutation-targeted Inhibition to Revolutionize Breast Cancer Treatment.Curr Pharm Des2025https://conductscience.org/library/papers/39421986PubMed

See all 260 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17417627

GET https://conductscience.org/api/papers/v1/17417627/cited_by?page=2